Can I Buy Alexion Pharmaceuticals Inc Shares in India?

Yes, Alexion Pharmaceuticals Inc shares can be bought in India by opening an international trading account with Groww.

How to Buy Alexion Pharmaceuticals Inc Shares in India?

One can easily invest in Alexion Pharmaceuticals Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Alexion Pharmaceuticals Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Alexion Pharmaceuticals Inc.

What is the Share Price of Alexion Pharmaceuticals Inc?

The share price of Alexion Pharmaceuticals Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Alexion Pharmaceuticals Inc share price is $182.50 as of 14 Dec ‘24

What is the Market Cap of Alexion Pharmaceuticals Inc?

The Alexion Pharmaceuticals Inc market cap is $40.33B as of 14 Dec ‘24

What is the PE and PB ratio of Alexion Pharmaceuticals Inc?

The PE and PB ratio of Alexion Pharmaceuticals Inc is 59.2 and 3.2 as of 14 Dec ‘24

Alexion Pharmaceuticals Inc Share Price, ALXN Stock Price Quote Today

<img alt="Alexion Pharmaceuticals Inc" srcSet=" 1x,  2x" src="" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
Alexion Pharmaceuticals Inc Healthcare 
$182.50
+3.05(1.70%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$181.04$182.5036,200,075
FundamentalsMarket Cap$40.33B
P/B Ratio3.2
P/E Ratio59.2
Enterprise Value$39.60B
Div. Yield0.00%
Book Value52.94
EPS(TTM)2.74
ROE5.40%
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanyAlexion Pharmaceutical, Inc. (NYSE: ALXN) is an American biopharmaceutical company founded in the year 1992. It conducts extensive researches on the immune system and autoimmune diseases. It is headquartered in Massachusetts, US. In 2011, with a market value of $8.5 million, Alexion was added to the NASDAQ-100. ALXN shares reached their all-time high closing price of $207.84 on July 23rd, 2015. As of 2020, the company’s net worth was $24.71 billion.  
Alexion Pharmaceutical, Inc. is best known for its development of Soliris, a medicine used to treat rare disorders such as aHUS and PNH. Soliris received approval from the US Food and Drug Administration (FDA) in 2007. In 2010, Germany saw an outbreak of Haemolytic-Uremic Syndrome (HUS) and Soliris was considered as a treatment option. The company also offers speciality drugs for other rare diseases such as gMG, HPP, LAL-D and NMOSD. In addition to Soliris, the company also developed Strensiq – a drug that treats Hypophosphatasia, a rare metabolic disorder. Alexion also acquired Kanuma, a medication for Lysosomal Acid Lipase Deficiency, a fatal genetic disorder. The company’s research segment focuses on the core therapeutic areas of neurology, haematology, metabolics, nephrology and cardiology.
Over the years, Alexion has acquired several leading companies. Some notable acquisitions include Proliferon Inc. in 2000, Enobia Pharma Corp in 2011, Syntimmune in 2018, Achillion Pharmaceuticals in 2019, and Portola in the year 2020. It received the Judge’s Prize in the 2018 Best Practices Award by Bio-IT World for its SmartPanel platform. The company was awarded the 2009 Prix Galien (The Galien Prize) for its Soliris medication. As of 2019, Alexion Pharmaceutical, Inc. ranked 41 in Fortune’s list of Future 50. In 2020, Alexion was also recognised by OSHA (Occupational Safety and Health Administration) for its commitment to workplace health and security. The company ranks 796 on Forbes’ list of Global 2000 2020 companies. It was also included in Forbes’ list of World Best Employers in 2020. As of 2020, the company operates in several regions worldwide like North America, Europe, Middle-East, Latin America, and the Asia-Pacific, among others.;
OrganisationAlexion Pharmaceuticals Inc
IndustryBiotechnology
HeadQuartersBoston, MA
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

Open Price	Prev. Close	Volume	Avg. Volume
$181.04	$182.50	3	6,200,075

Market Cap	$40.33B
P/B Ratio	3.2
P/E Ratio	59.2
Enterprise Value	$39.60B

Organisation	Alexion Pharmaceuticals Inc
Industry	Biotechnology
HeadQuarters	Boston, MA